Gujarat Terce Laboratories Ltd — Quarterly Results & Earnings

₹30.90

-2.42%

Profit Growth YoY-5.41%Latest quarter

Sales Growth YoY-2.78%Latest quarter

Sales CAGR 5Y5.98%5 year compound

Profit CAGR 5YN/A5 year compound

📋

Quarterly Performance

YoY Profit Growth-5.41%

⚠️ Mild contraction

YoY Sales Growth-2.78%

⚠️ Mild contraction

OPM 5Y Average

Operating profit margin

0.72%

EPS Growth 5Y

N/A

Interest Coverage

Higher = safer debt servicing

14.52

ROE

-14.57%

ROCE

41.41%

💡

Growth Analysis

Gujarat Terce Laboratories Ltd reported YoY profit growth of -5.41% and revenue growth of -2.78% in the latest quarter. Mild profit contraction — investigate if one-time or structural. Over 5 years, sales compounded at 5.98% and profits at N/A annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Gujarat Terce Laboratories Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.